INS and neoplasm: This progression may explain why diabetes often emerges following tumour growth—initially, β-cells may be overstimulated and promote tumourigenesis through endocrine–exocrine signalling, but as the tumour expands and disrupts normal pancreatic architecture, β-cell function declines, leading to insulin insufficiency and diabetes onset.